Рак молочной железы

Guy Jerusalem: How Can Biomarkers Guide Breast Cancer Treatment De-escalation?

Guy Jerusalem: How Can Biomarkers Guide Breast Cancer Treatment De-escalation? oncodaily.com

Camizestrant Combo Misses PFS End Point in First-Line ER+/HER2– Breast Cancer

Scientists discover strange link between low vitamin D and pain

Low vitamin D levels may make recovery from breast cancer surgery more painful, according to a study of 184 women undergoing mastectomy. Patients with vitamin D deficiency were three times more likely to experience moderate to severe pain during the first 24 hours after surgery and also used substantially more of the…

Data-driven tool to help oncologists identify high-risk periods for metastatic breast cancer patients

Oncologists know that intensive treatment rarely helps patients in their final days, but recognizing when someone is entering that stage is difficult, especially in metastatic breast cancer, where an increasing number of effective treatments has helped prolong life and given patients and oncologists more treatment…

Data Safety Monitoring Board Recommends Continuing BriaCell's Phase 3 Metastatic Breast Cancer Study

Data Safety Monitoring Board Recommends Continuing BriaCell's Phase 3 Metastatic Breast Cancer Study Investing News Network

AZ's Etcamah falls short in first-line breast cancer trial

AZ's Etcamah falls short in first-line breast cancer trial pharmaphorum

A breast cancer trial gets a seventh recommendation to continue

A breast cancer trial gets a seventh recommendation to continue Stock Titan

У мужчин обнаружен рак груди

У мужчин обнаружен рак груди vietnam.vn

AstraZeneca's Etcamah misses Phase III first-line breast cancer endpoint

AstraZeneca's Etcamah misses Phase III first-line breast cancer endpoint AllSci

AstraZeneca Breast Cancer Combination Treatment Misses Main Target in Late-Stage Study

AstraZeneca Breast Cancer Combination Treatment Misses Main Target in Late-Stage Study Yahoo Finance UK

NUS Scientists Harness Magnetic Pulses to Reprogram Immune Cells to Fight Breast Cancer | Newswise

NUS Scientists Harness Magnetic Pulses to Reprogram Immune Cells to Fight Breast Cancer | Newswise Newswise

Attorney enrolled in breast cancer vaccine trial to speak at St. Andrew’s Oct. 18

Attorney enrolled in breast cancer vaccine trial to speak at St. Andrew’s Oct. 18 Mountain Home Observer

AstraZeneca's Phase 3 Trial of Combination Treatment for Breast Cancer Fails to Meet Primary Endpoint

AstraZeneca's Phase 3 Trial of Combination Treatment for Breast Cancer Fails to Meet Primary Endpoint marketscreener.com

New analysis points to low overdiagnosis in breast cancer screening

When women take part in breast cancer screening, they are informed that screening may detect cancers that would never have caused symptoms or problems during their lifetime. This is known as overdiagnosis.

AstraZeneca's oral SERD stumbles in Phase III first-line breast cancer trial

AstraZeneca's oral SERD stumbles in Phase III first-line breast cancer trial FirstWord Pharma